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ABSTRACT 
PROMOTING SELF-EFFICACY AMONG HEAD AND NECK 
CANCER PATIENTS 
Current survivorship visits at the Stanford head and neck oncology program 
are not standardized to address ongoing post-treatment sequelae. The objectives of 
this study help to address whether current non-standardized visits actually help to 
empower patients to self-manage their chronic diagnosis of head and neck cancer 
by measuring their self-efficacy levels before and after their post-treatment 
survivorship visit.  
Given the convenience sampling method, 17 patients were enrolled in 
this quasi-experimental pilot study. Demographic information was collected for 
each patient: gender, ethnicity, smoker status, and age. Head and neck cancer 
patients would first be surveyed before and after their follow up visit using the 
data collection tools: ChronicIllness Management Self-Efficacy Scale or the 6-
item General Self- efficacy scale.  One sided t tests and ANOVA were used for to 
compute and examine the statistical significance of improved self-efficacy values. 
Current non-standardized survivorship follow- up visits designed with a written 
treatment summary have shown to improve self-efficacy levels. Age and smoking 
status were found to be statistically significant confounding factors.  
Transition survivorship visits should aim to improve self-efficacy levels 
among head and neck cancer survivors. American Cancer Society guidelines for 
follow up care can guide the conversations of survivorship issues and facilitate 
communication between cancer specialists and community providers. 
Lily Lam  
May 2019 
DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638
DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638
PROMOTING SELF-EFFICACY AMONG HEAD AND NECK 
CANCER PATIENTS 
 
 
 
 
 
 
 
by 
Lily Lam 
 
 
 
 
 
 
A project 
submitted in partial 
fulfillment of the requirements for the degree of 
Doctor of Nursing Practice 
California State University, Northern Consortium 
Doctor of Nursing Practice 
May 2019 
DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638
APPROVED 
For the California State University, Northern Consortium 
Doctor of Nursing Practice: 
 
We, the undersigned, certify that the project of the following student 
meets the required standards of scholarship, format, and style of the 
university and the student's graduate degree program for the 
awarding of the Doctor of Nursing Practice degree. 
 
 
 
  Lily Lam  
Project Author 
 
 
  
Constance Hill (Chair) Nursing 
 
 
  
Vasu Divi Stanford 
 
 
  
Deepa Shah Stanford 
 
 
 
 
DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638
AUTHORIZATION FOR REPRODUCTION 
OF DOCTORAL PROJECT 
 
            x  I grant permission for the reproduction of this project in part or in 
its entirety without further authorization from me, on the 
condition that the person or agency requesting reproduction 
absorbs the cost and provides proper acknowledgment of 
authorship. 
 
 
  Permission to reproduce this project in part or in its entirety must 
be obtained from me. 
 
 
 
 
 
 
 
Signature of project author:    
DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638
ACKNOWLEDGMENTS 
I would like to take the time to express my deep gratitude to following 
individuals who have supported and encouraged me through this project. I would 
like to give sincere thanks to my project Chair, Dr. Constance Hill who has guided 
me through this project as well as my Program Advisor, Dr. Lisa Walker-Vischer 
for keeping me calm during panicked phone calls.  Without the encouragement 
and guidance of you both, this project would not have come to fruition. I would 
also to thank my committee members, Dr. Vasu Divi and Deepa Shah, PA-C who 
have been great resources and mentors for my project at Stanford.  
I would to also take the time to thank my work colleagues who allowed me 
to take the time to climb up the education ladder to expand my knowledge. Thank 
you for covering my patients when I needed to take the time off to complete this 
program. My fellow DNP classmates thank you for your unwavering support and 
encouragement to complete the program together. Last but not the least, my 
friends and family, I thank you especially for keeping me in check in my doctoral 
journey.  
 
DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638
TABLE OF CONTENTS 
 Page 
LIST OF TABLES .................................................................................................. vi 
CHAPTER 1: INTRODUCTION ............................................................................ 1 
Background: Cancer as a Chronic Illness ......................................................... 1 
Theoretical Framework ..................................................................................... 3 
Aim of Study ..................................................................................................... 4 
CHAPTER 2: LITERATURE REVIEW ................................................................. 6 
Gaps in Literature ............................................................................................. 6 
Previous Literature ............................................................................................ 7 
CHAPTER 3: METHODOLOGY ......................................................................... 12 
CHAPTER 4: RESULTS AND DISCUSSION ..................................................... 15 
Self-Efficacy Changes .................................................................................... 15 
Demographic Effects ...................................................................................... 17 
Summary ......................................................................................................... 26 
CHAPTER 5: CONCLUSION ............................................................................... 28 
REFERENCES ....................................................................................................... 30 
APPENDICES ........................................................................................................ 34 
APPENDIX A: SELF-EFFICACY FOR MANGING CHRONIC DISEASE 6-
ITEM SCALE ............................................................................................. 35 
APPENDIX B: GENERAL SELF-EFFICACY SCALE ....................................... 37 
DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638
LIST OF TABLES 
 Page 
Table 1  SCIMSS (Post -Pre) ................................................................................. 16 
Table 2  GSE (Post-Pre) ........................................................................................ 17 
Table 3 SCIMSS (Age) ........................................................................................... 19 
Table 4 GSE (Age) ................................................................................................. 19 
Table 5  Self-Efficacy (Gender) .............................................................................. 20 
Table 6  GSE (Gender) ........................................................................................... 21 
Table 7  Self-Efficacy (Smoker) .............................................................................. 22 
Table 8  GSE (Smoker) ........................................................................................... 23 
Table 9  SCIMSS (Ethnicity) .................................................................................. 24 
Table 10  GSE (Ethnicity) ...................................................................................... 25 
 
 
 
 
 
 
 
 
 
DocuSign Envelope ID: 64394316-7876-4DB5-BD24-678B195D5638
   
CHAPTER 1: INTRODUCTION 
Background: Cancer as a Chronic Illness 
The burden of chronic illness care and management is on the rise in the 
United States (Centers for Disease Control and Prevention, 2017). Concurrent 
chronic illnesses that may also be linked and affect multiple organ or physiological 
systems. Chronic illness is filled with uncertainty as the predictability of outcomes 
is heavily influenced by self-management, access to healthcare, resources in the 
community, and care coordination. Chronic illness is responsible for variable and 
constant disruptions from going about and proceeding with normal daily activities. 
Management of chronic illnesses is reliant on the understanding of the diagnoses, 
coping with the conditions, handling day to day disruptions, and coming to terms 
with living with their diagnosis.  
Healthcare in the United States is heavily weighted as acute care 
management and short-term disease management rather than chronic illness 
prevention. With this focus on acute care management, the burden of chronic 
illness management increases. Current healthcare systems lack processes and 
instruments for chronic illness management, which is often difficult to implement 
during an acute care episode. Given the complexities involved in chronic illness 
management, it requires a delivery system that is comprehensive and inconclusive 
of community resources. It needs to be encouraging of self-management and 
promoting healthy behaviors across the lifespan for optimal outcomes. Shifting 
health care from acute focused and episodic care focus to promote preventative 
healthcare and healthy behaviors across the lifespan is essential to address the 
increasing needs of those who are chronically ill.  
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Cancer is defined as a chronic illness (Hebdon, Foli, & McComb, 2015). 
The transition from active treatment for the cancer patient to survivorship can be a 
period of uncertainty for the patient and their families. This is due to the 
“ambiguity of their illness state, treatment complexity, information gaps, and 
unpredictable disease course” (Hebdon et al., 2015, p.1776). The undertreated and 
overlooked survivorships issues specifically for head and neck cancer patients 
need to be addressed to promote overall positive outcomes. Multiple psychosocial, 
and physical sequela from active treatment is known and predictable.  
Survivorship includes issues related to the ability to get healthcare and follow-up 
treatment, late effects of treatment, second primary cancers, and quality of life 
(Simcock & Simo, 2016). Other survivorship issues include: dental care, trismus, 
hypothyroidism, swallowing, xerostomia, second cancers, smoking and alcohol, 
vascular injury, ototoxicity, financial, depression, and quality of life (Simcock & 
Simo, 2016).  Multiple providers can share the responsibilities of managing the 
patients with head and neck cancer, which may increase the opportunity for 
conflicting information for the management of their chronic conditions. This can 
result in unnecessary duplication of imaging or other diagnostic tests, driving up 
the costs of healthcare, and become frustrating for the patient. As five-year 
survival rates continue to rise due to improvements in cancer treatment protocols 
and continued evidence-based practice, the number of head and neck cancer 
survivors needing to be managed increase.  
The transition from active treatment to maintaining stability and living with 
the chronic illness can only happen by empowering the patient, maintaining 
patient-provider relationships, and continued adjustment and flexibility in 
management for each individual patient. The Institute of Medicine has highlighted 
the importance of addressing cancer survivorship issues for long term 
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improvement of health outcomes. One of the simple mechanisms recommended to 
improve quality of life of a cancer survivor is the implementation of completed 
cancer treatment plans in follow up visits for a cancer survivor and ongoing plan 
for continued surveillance (Committee on Cancer Survivorship, 2006). An 
effective survivorship care visit and transition plan can help with the uncertainty 
of cancer as a chronic illness during the transition to routine follow up. Inability to 
create appropriate treatment plans and continued management can lead to 
fragmented and gaps in care, ultimately resulting in poor outcomes. 
Theoretical Framework 
Bandura’s (1982) exploration of self-efficacy beliefs as an element of the 
social cognitive theory help describes a person’s willingness and motivations to be 
able to make the outcomes, they want by the actions they take. The self-efficacy 
beliefs can also be used to explain how an individual can respond to the 
unexpected adversary or stressful events in their lives; it can be used to describe 
their outlook on the outcomes of a situation and the choices that may make as a 
response. Self-efficacy beliefs can influence the course of actions a person may 
take, usually completed tasks reflect competence and confidence. Self-efficacy 
beliefs are formed when a person engages in activities and actions that are then 
interpreted to be either beneficial or missteps. They begin to develop an idea or 
belief that they are capable of continuing the course of action that would be 
interpreted as valuable. In fact, the beliefs of self-efficacy have been used to guide 
and frame the development of chronic diseases management.  
Cancer as a chronic illness requires management over a longer period of 
time. A patient’s health beliefs and self- efficacy can play a large role in the 
successful management of the psychological and physical tolls of cancer. Self-
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efficacy in this regard is the theorized level of confidence a patient or their 
caregiver may have in managing some of the psychological and physical sequelae 
of active cancer treatment. Patients with measured higher levels of self-efficacy 
tend to be able to better self-manage their chronic illnesses (Foster et al., 2015, 
p.11). These patients are more self-aware of the care needed to continue moving 
forward and actively participate in the decision-making process in addressing the 
sequela of cancer treatment. Patients who are able to successful self-manage make 
decisions to enhance and maintain their quality of life, ultimately leading to better 
health outcomes. Patients who have higher levels of self-efficacy have higher 
levels of belief that they can alter and change their health behavior in order to 
promote certain outcomes.  
Aim of Study  
Prior cancer survivorship studies show a clear absence of succinct 
transitions of care for head and neck cancer patients after cancer treatment which 
impact their quality of life and health outcomes. The Institute of Medicine has 
highlighted the importance of addressing cancer survivorship issues for long-term 
improvement of health outcomes. Hypothesized mechanisms to increase overall 
survival and improved quality of life for surviving head and neck cancer patients 
is to empower them with the knowledge of their completed treatment plan, and to 
provide written expectations of follow up care in order to address issues of 
survivorship: acute and long-term late effects of treatment, prevention of 
secondary cancers, cancer surveillance for recurrence, and coordination of care. 
National cancer guidelines for ongoing management frame the recommendations 
for follow up care in cancer care as patients enter into a period of watchful 
waiting. Cancer as a chronic illness requires management over a longer period of 
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time. A patient’s health beliefs and self-efficacy can play a large role in the 
successful management of the psychological and physical tolls of cancer.  Self-
efficacy in this regard is the theorized level of confidence a patient or their 
caregiver may have in managing some of the psychological and physical sequelae 
of active cancer treatment.  
Current survivorship visits at the Stanford head and neck oncology program 
are not standardized to address ongoing post-treatment sequalae. The lack of a 
standard survivorship care plan allows for the flexibility of information delivered 
and is consequently reliant on the knowledge base of the head and neck oncologist 
determining what information is vital. Patients are given access to electronic chart 
notes that highlight a treatment summary and a written follow up care plan 
designed by their oncologist.  Survivorship templates are being created by the 
American Society of Clinical Oncology to highlight key elements that should be 
included in care plan components such as treatment summary and follow up 
recommendations but are not utilized in the Stanford head and neck oncology care 
program. The aims of this research will help to answer if non-standardized current 
survivorship visits with written treatment summary and plan for head and neck 
cancer patients currently help to improve self-efficacy to enhance self-
management of acute and long-term effects of their cancer treatments. The 
objectives of this study help to address whether current non-standardized visits 
actually help to empower patients to self-manage their chronic diagnosis of head 
and neck cancer by measuring their self-efficacy levels before and after their post-
treatment survivorship visit.  
The hypothesis was made that currently head and neck cancer patients 
treated in the Stanford head and neck oncology program do not exhibit higher 
levels of self-efficacy in the current non-standardized survivorship visit.  
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CHAPTER 2: LITERATURE REVIEW 
Gaps in Literature  
A literature review of head and neck cancer survivorship transitions and 
existing use of survivorship care plans revealed a number of qualitative or 
descriptive studies available discussing the need of a survivorship care plan among 
this population in order to improve quality of life issues. CINAHL database was 
used to search for squamous cell carcinoma of head and neck, resulted in 13 
articles. A second search using the CINAHL database for key terms, cancer 
survivorship, and self-efficacy resulted in 20 articles. A third search for 
survivorship care plans resulted in 321 articles. Not all articles were related to 
head and neck cancer survivorship. There were limited articles, but what was 
noted to be true was that self-advocacy and self-efficacy are contributing factors to 
better health outcomes in the cancer survivor population. Given the gaps in the 
literature addressing the head and neck cancer population, it is pertinent to 
investigate if survivorship transition visits with written treatment summaries and 
follow up plan will improve self-efficacy and empowerment for head and neck 
cancer patients in the management of acute and long-term effects of cancer 
treatment. The articles presented in this literature review do not discuss in detail 
all articles related to head and neck cancer survivorship but are most pertinent for 
this study. 
A literature review of current survivorship transition tools for head and 
neck cancer patients highlights the lack of a standard tool that had measurable 
outcomes for increasing a HNC patient's quality of life and confidence in self-
management of their chronic illness. Several qualitative studies of cancer 
survivors address the need and importance of having a written treatment summary 
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as well as a follow-up plan in order to improve quality of life outcomes. There 
were no studies measuring head and neck cancer patient confidence in advocating 
for their continued health issues. The studies that are available do not address the 
very distinct head and neck population in Northern California. This study aims to 
address how the survivorship visits with written treatment plans and summaries 
affect self-efficacy among specifically head and neck cancer survivors.   
Previous Literature 
The previous prospective and observation outcomes study by authors Funk, 
Karnell and Christensen (2012) examined health related quality of life (HRQOL) 
among 5-year head and neck cancer survivors. They wanted to examine the long-
term impact of HRQOL among head and neck cancer survivors. By identifying 
specific characteristics of this patient population, the authors were hoping to be 
able to predict and determine HRQOL among specific patients. This study used 
univariate analysis and multivariate regression analysis to review their data. This 
particular analysis method was crucial in being able to find relationships between 
head and neck cancer patient characteristics and HRQOL outcomes. The 
conclusions drawn from the statistical analysis looking at HNC long-term health 
outcomes were used to describe how important it is for future research to improve 
interventions to improve health outcomes in the various categories of eating, 
speech, aesthetics, social disruptions, physical health, mental health, and overall 
quality of life. The limitations of this study did not examine several other factors 
that could contribute to also worse quality of life outcomes such as socioeconomic 
factors, insurance, health literacy, or social support networks as well. Despite quite 
a large sample population in a long-term study, the sample population was drawn 
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from one geographic area and institution. The results of this study may not 
necessarily be generalizable to all HNC patients at other institutions.  
In a smaller qualitative study conducted by the authors Nund, Ward, 
Scarinci, Cartmill, Kuipers, and Porceddu in 2014, head and neck cancer patients 
were interviewed to collect information from the patient perspective on speech and 
swallowing issues and access to services. Open ended interviews were conducted, 
and statements were coded into categories where participants shared similar 
comments.  Key themes were identified in the survivorship periods to use in 
futures studies for exploration. Conclusions drawn from these themes and 
interviews had significant implications on clinical practice. The authors were able 
to give clear suggestions of future research and design of interventions in order to 
address what is patient perceived issues of speech and swallowing following 
cancer treatment and as well as healthcare practitioner access in managing these 
issues. This study looks at specifically one post-treatment sequelae head and neck 
cancer patients face during the management of their chronic diagnosis. This study 
did however account for a patient’s perspective on post-treatment issues which is 
essential in modifying healthy behaviors and increasing compliance. Further 
studies would need to be conducted in order to address many other post-treatment 
sequelae as well.  
Kenzik et al. (2016) study looks at specifically the relationship between 
treatment summaries with self-efficacy and healthcare use for cancer survivors. 
This was a cross-sectional quantitative study conducted among 12 various 
hospitals across five states of which all cancer patients were eligible as long as 
they would be able to participate in this study. The authors used the Stanford 
Chronic Illness Self-Efficacy scale as well as collected demographics and clinical 
information to assess for covariance. Three multiple linear regression analysis 
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were used for categorical and continuous variables. The strengths of this study 
were the large sample size of cancer patients was considered in this study at 12 
different institutions spread across five different states. This was a quantitative 
study that provided information on the external validity of how transitions impact 
care and health outcomes. The authors of the study were able to find positive 
associations between verbal explanations of follow up care plans to improve self-
efficacy which then provides a foundation for the hypothesis of how survivor self-
efficacy could impact decreased emergency room visits and hospitalizations. The 
limitations of the study as indicated by the authors were of the reliance of patients 
to self-report receiving any of the models of care including treatment summaries, 
written follow up care information and verbal follow up care plans. Other 
limitations of this study were that it only identified quite a heterogeneous 
population of cancer survivors (mainly breast and prostate cancers) and those over 
the age of 65. This particular study does not focus on the very specific head and 
neck cancer population who has different and varying post-treatment physical and 
psychosocial sequelae than the other cancer populations.  
When looking at the relationship between the post-treatment experiences of 
oral cavity and oropharyngeal cancer survivors, the authors Manne et al. (2016) 
conducted a cross-sectional study to help identify continuing needs of the oral 
cavity and oropharyngeal cancer survivors. These authors similar to the previous 
study were looking at using patient demographics and characteristics to identify 
any association with support and information needs. Combined data analysis was 
used in this studying including, t-tests for evaluating continuous variables and 
stepwise regression for demographic medical and psychological variables. 
Bivariate associations were evaluated between background variables and total 
information and psychosocial support needs.  The authors were able to identify a 
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comprehensive set of priority needs in this specific cancer survivor population. 
Patients were found to have majority of their ongoing management care by their 
oncologist rather than their primary care provider. It is important for healthcare 
providers to realize that cancer patients would like more information regarding 
late and long-term effects of their treatment. This study highlights a specific head 
and neck cancer subset among head and neck cancer survivors in one geographic 
location. The authors highlight the need for written treatment summaries and the 
discussion regarding acute and late effects of treatment. The authors of this study 
do not discuss the levels of self-efficacy as an indicator of confidence levels 
needed to manage their ongoing issues in the survivorship period.   
Building on previous studies, the authors Mayer et al. (2016) conducted a 
pilot randomized controlled study to compare the effectiveness of a survivorship 
care plan (SCP) transition visit with a SCP transition visit in addition to a 
coordinated follow up visit with the patient’s primary care physician (Mayer et al., 
2016). The authors conducted this study at the REX Cancer hospital, a community 
cancer center in Raleigh, North Carolina. 34 adult cancer patients were enrolled in 
this study; they were randomized to two arms: survivorship care plan visit with 
coordinated follow up with primary care providers or survivorship care plan visits 
only. The authors were answering the question on the patient confidence in 
survivorship information, the expectations for cancer survivorship care and 
satisfaction with care. The authors were also measuring the feasibility of the 
intervention as well. Descriptive statistics were used as well as Wilcoxon rank 
sum tests for data analysis. Mayer, et al. were able to draw conclusions that it was 
indeed feasible to conduct this intervention in a larger population or even more 
specific cancer survivor population in order to learn more information about the 
impact of survivorship care plan visits. Patients had increased worry with the 
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receipt of a survivorship care plan, but those levels of worry decreased when these 
patients have a follow up visit with their primary care providers. This particular 
study was relatively small for a randomized control trial and did not clearly state 
which type of cancer patients they were studying.  The results of a survivorship 
care plan’s impact on different cancer survivors are also variable in that each 
cancer patient population has unique needs.  
Self-efficacy is a widely used theory to describe how a person’s confidence 
and beliefs frame the actions they take to create solutions to problems they face. In 
the application of this social cognitive theory to patients with chronic illnesses, 
self-efficacy beliefs have a major influence on how motivated patients are in 
complying with a treatment plan. A literature review of the current survivorship 
care dedicated for head and neck cancer patients show that there is a gap of studies 
highlighting how best to improve survivorship for head and neck patient 
population by addressing self-efficacy. Some of the current studies available for 
review have been conducted to look at the health-related outcomes in terms of 
survivorship care planning for all cancer patient populations and generalizations 
from these studies cannot be applied to the very specific head and neck cancer 
population. There were no specific studies looking at the relationship between 
self-efficacy and head and neck cancer survivorship issues. Bandura’s theory of 
self-efficacy helps frame this study to address the gap in literature looking at how 
confident a head and neck cancer patient is in addressing ongoing post-treatment 
issues via a guided survivorship transition visit with their healthcare practitioner.  
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CHAPTER 3: METHODOLOGY 
Design and Sample 
The sampling method for this quasi-experimental study was of 
convenience. The idea of a transition tool and standardized head and neck 
survivorship clinic visit is still being established at Stanford. A simple random 
sampling in which patients who fit the inclusion criteria would be randomly 
selected to be surveyed would be ideal. However, in order to get a larger number 
of patients to participate, convenience sampling was most feasible. Given the 
convenience sampling method, 17 patients were enrolled in the study. Subjects 
were enrolled during October 2018 - January 2019 for data collection and 
screening. Demographic information was collected for each patient: gender, 
ethnicity, smoker status, and age (either above 65 or younger than 65). Analysis of 
participants' surveys were conducted from January -February 2019. The study took 
place at the Stanford outpatient head and neck oncology clinic. Stanford 
Hospital/Cancer Center IRB approval was obtained in order to enroll patients in 
this population. The visits were conducted by nurse practitioners and physicians. 
The total time of recruitment and survey conducted was approximately 10-15 
minutes.  
Participants 
Head and neck cancer patients who have received at least two treatment 
modalities for head and neck cancer were eligible for participation as long as they 
received at least one modality of treatment at Stanford within the last five years. 
The sample population differs from other samples of other researchers in the 
literature review given the diversity of the HNC population at Stanford, a large 
academic tertiary center for care. Patients are coming from various socio-
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economic backgrounds; confounding factors that could contribute to improving 
self-efficacy were considered. Patients who cannot read or understand English 
were excluded from this study; they can be evaluated at a later phase of the 
clinical trial. Head and neck cancer patients screened were able to read the waiver 
of authorization for consent. They needed to be able to verbalize their consent for 
the study. Patients who were enrolled to participate in this study were scheduled 
for a survivorship visit. The providers (NPs/PAs/MDs) reviewed their patients’ 
chart at the time that they are seeing the patient in clinic via EPIC (electronic 
medical record system) and asked their patient if they were willing volunteer to 
participate in the study if they met eligibility criteria. 
The general sample population consisted of 17 patients. Eight patients were 
older than 65, and nine patients were younger than 65. There were five females 
and twelve males that completed the survey. There were two Asians, thirteen 
Caucasians, and two Hispanics enrolled in the study. There were thirteen non-
smokers and four former smokers in the survey. 
Tools for Measurement 
During the visit, the patients would first be surveyed using the data 
collection tool: ChronicIllness Management Self-Efficacy Scale or the 6-item 
General Self- efficacy scale. As part of the visit, HNC patients will be given a 
written treatment summary and continued plan of treatment (transition tool 
intervention) for standard care. Following the visit, participants will then be again 
surveyed using the data tools. The scales/tools are available for use by an 
individual without permission given funding from the National Institute of 
Nursing Research. There are easily downloaded from the Self-Management 
Resource Center website.  
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Instrument 1. The Stanford Chronic Illness Management Self-Efficacy 
Scale (SCIMSS) was used as a pre-and post-intervention survey for data 
collection. The original scale has various survey questions about the confidence of 
patients in several areas in a range of 1-10, 10 being totally confident. The areas of 
CIMSES that are specifically addressing self-efficacy and confidence in self-
management of cancer as a chronic illness include: getting information about the 
disease, obtaining help from community, family, friends scale, communicating 
with physician scale, managing disease in general scale, and managing of 
symptoms scale. The tool has been normed on a range of a number of participants, 
292-478 and have a internal consistency reliability of .77 - .92 with a test and 
retest reliability of .72-.89.  
Instrument 2. The short form 6-item GSE (General Self-Efficacy Scale) 
created by Schwarzer and Jerusalem (1995) which has a Cronbach's alpha between 
.79 and .88 was also used for data collection. This instrument has been validated 
and used in assessing self-efficacy in chronic illness management. This scale was 
tested on 605 patients with chronic disease and has an internal consistency 
reliability score of .91.  
Data analysis  
Descriptive statistical analyses were performed on the sample groups to 
obtain a clear understanding of the population. One sided t tests and ANOVA were 
used for to compute and examine whether the follow up survivorship visits 
improve self-efficacy values for the head and neck patient population.  
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CHAPTER 4: RESULTS AND DISCUSSION 
Self-Efficacy Changes  
For the six SCIMSS questions and the ten GSE questions, statistical tests 
were performed to see if the mean responses are statistically improved for the 
post- versus the pre-survivorship visits scores by the patients.  These are one-sided 
tests because we assume that the mean post responses are either greater than the 
pre-responses or equal.  
Table 1 summarizes the results for the SCIMSS questions.  For each 
question, the mean score (averaged over the seventeen responses) is listed along 
with the standard deviation.  The t statistic for testing if the population mean 
difference is greater than zero is then displayed.  The p value is the level of 
significance which transfers the t statistic based on a one-tailed test with 16 
degrees of freedom.  The same analysis is done for the average of the six GSE 
questions, which is in the last row. 
A p value below 0.05 is considered to be statistically significant implying 
higher scores after counseling than before counseling. Question SCIMSS -1 was 
found to be statistically significant. SCIMSS -1 asks how confident patients feel 
they can manage their fatigue from interfering with the things they do. The 
average of patients’ confidence levels has improved when asked about managing 
their fatigue. Patients do not show an overall improvement in self-efficacy with 
the current scheduled survivorship visit with written treatment plan via the 
SCIMSS scale. Given that there is no statistical significance in the average pre and 
post- visit self-efficacy levels as captured in the surveys, the hypothesis remains 
correct, patient’s do not report increased self-efficacy with the current 
survivorship transitional follow up visit using the SCIMSS scale.  
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Table 2 contains the same analysis for the GSE questions.  Questions GSE-
2 and GSE-9 were found to be statistically significant.  The average for all ten 
GSE questions was also found to be statistically significant. Using the GSE scale, 
patients do report levels of higher self-efficacy following the survivorship 
transition visit. The hypothesis is proven to not be true, self-efficacy levels 
increase with the current survivorship visits with written treatment plans using the 
GSE Scale.  
Table 1 
 
SCIMSS (Post -Pre) 
 Questions Mean 
St. 
Dev. t p 
SCIMSS-1 0.235 0.437 2.22 0.021 
SCIMSS-2 0.176 0.529 1.38 0.094 
SCIMSS-3 -0.176 0.809 -0.90 0.809 
SCIMSS-4 0.059 0.429 0.57 0.290 
SCIMSS-5 0.059 0.748 0.32 0.375 
SCIMSS-6 -0.059 0.243 -1.00 0.834 
SCIMSS-
Average 0.049 0.275 0.74 0.236 
Note. SCIMSS-1(in bold) is statistically significant (p <0.05). 
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Table 2 
 
GSE (Post-Pre) 
Questions  Mean St. Dev. t p 
GSE-1 0.059 0.429 0.57 0.290 
GSE-2 0.176 0.393 1.85 0.041 
GSE-3 0.000 0.000 ------- ------- 
GSE-4 0.000 0.500 0.00 0.500 
GSE-5 -0.059 0.243 -1.00 0.834 
GSE-6 0.059 0.243 1.00 0.166 
GSE-7 0.000 0.000 ------- ------- 
GSE-8 0.059 0.243 1.00 0.166 
GSE-9 0.235 0.437 2.22 0.021 
GSE-10 0.059 0.429 0.57 0.290 
GSE-Average 0.059 0.087 2.79 0.007 
Note. GSE-2, GSE-9, and GSE-Average highlighted in bold is statistically 
significant (p <0.05) 
Demographic Effects 
Age 
Demographic factors were examined to look at the effect made on any 
improvements in self-efficacy.  The first factor analyzed was age.  The age of the 
seventeen patients is partitioned into two groups.  The first group consists of eight 
patients who are older than 65.  The second group consists of nine patients who 
are younger than 65.   
In Table 3, for each of the six SCIMSS questions as well as the averages 
over the six questions, the means for the two age groups are listed, as well as the 
respective standard deviations.  The next column is the t statistic for testing the 
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null hypothesis that the population means for the two groups are equal, against the 
alternative hypothesis that the two population means differ.  The p value (also 
known as the level of significance) is based on the t distribution with 15 degrees of 
freedom.  A p value below 0.05 is considered to be statistically significant.  None 
of the SCIMSS responses are determined to be affected by the age factor. Age was 
not a confounding factor when looking at increased self-efficacy levels following 
a survivorship visit using the SCIMSS scale. 
Table 4 consists of the same analysis for the GSE questions.  On question 
GSE-9, the older patients tended to record statistically greater improvements than 
the younger patients.  That specific question is bolded. Age was a confounding 
factor in improved self-efficacy levels following a transitional survivorship visit 
for patients older than 65 using the GSE scale. Patients who are younger than 65 
do not have a reported increase in self-efficacy level following their survivorship 
visit.  
Conclusions can be made that age influences reports of self-efficacy levels 
if we consider the statistical significance of the averages on pre and post-test were 
unchanged on SCIMSS and higher on the GSE survey. 
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Table 3 
SCIMSS (Age) 
  Mean St. Dev. 
t p 
 Questions  Older  Younger Older  Younger 
SCIMSS-1 0.250 0.222 0.463 0.441 0.13 0.901 
SCIMSS-2 0.000 0.333 0.000 0.707 -1.33 0.203 
SCIMSS-3 -0.125 -0.222 0.354 1.093 0.24 0.813 
SCIMSS-4 0.000 0.111 0.000 0.601 -0.52 0.609 
SCIMSS-5 -0.125 0.222 0.835 0.667 -0.95 0.355 
SCIMSS-6 0.000 -0.111 0.000 0.333 0.94 0.362 
SCIMSS-Average 0.000 0.093 0.236 0.313 -0.68 0.505 
Table 4 
GSE (Age) 
  Mean St. Dev. 
t p 
 Questions Older  Younger Older  Younger 
GSE-1 0.125 0.000 0.354 0.500 0.59 0.565 
GSE-2 0.000 0.333 0.000 0.500 -1.88 0.079 
GSE-3 0.000 0.000 0.000 0.000 ------- ------- 
GSE-4 0.000 0.000 0.535 0.500 0.00 1.000 
GSE-5 -0.125 0.000 0.354 0.000 -1.07 0.303 
GSE-6 0.000 0.111 0.000 0.333 -0.94 0.362 
GSE-7 0.000 0.000 0.000 0.000 ------- ------- 
GSE-8 0.000 0.111 0.000 0.333 -0.94 0.362 
GSE-9 0.500 0.000 0.535 0.000 2.82 0.012 
GSE-10 0.125 0.000 0.354 0.500 0.59 0.565 
GSE-Average 0.063 0.056 0.074 0.101 0.16 0.876 
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Note. GSE-9 highlighted in bold is statistically significant (p <0.05).  
Gender 
Gender was compared as a factor in affecting the responses.  There were 
five females and twelve males in the survey.   In Table 5, the means for both 
genders are listed along with the pooled standard deviation.  The t test statistic is 
listed with the corresponding p value.  The p value is based on the t distribution 
with 15 degrees of freedom.  On none of the SCIMSS questions was gender found 
to be a statistically significant factor in affecting the differences.  The same is true 
for the SCIMSS averages. The same analysis was done for the GSE questions in 
Table 6.  No statistically significant effects due to gender were found. Gender did 
not play a role in improved self-efficacy levels following a survivorship visit with 
written treatment summary.  
Table 5 
 
Self-Efficacy (Gender) 
  Mean St. Dev. 
t p 
 Questions Female Male Female Male 
SCIMSS-1 0.200 0.250 0.447 0.452 -0.21 0.838 
SCIMSS-2 0.000 0.250 0.000 0.622 -0.88 0.391 
SCIMSS-3 -0.200 -0.167 0.447 0.937 -0.07 0.941 
SCIMSS-4 0.000 0.083 0.000 0.515 -0.36 0.727 
SCIMSS-5 -0.400 0.250 0.894 0.622 -1.73 0.102 
SCIMSS-6 0.000 -0.083 0.000 0.289 0.63 0.535 
SCIMSS-Average -0.067 0.097 0.253 0.279 -1.13 0.275 
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Table 6 
 
GSE (Gender) 
  Mean St. Dev. 
t p 
 Questions Female Male Female Male 
GSE-1 0.000 0.083 0.000 0.515 -0.36 0.727 
GSE-2 0.000 0.250 0.000 0.452 -1.21 0.243 
GSE-3 0.000 0.000 0.000 0.000 ------- ------- 
GSE-4 0.200 -0.083 0.447 0.515 1.07 0.301 
GSE-5 -0.200 0.000 0.447 0.000 -1.63 0.123 
GSE-6 0.000 0.083 0.000 0.289 -0.63 0.535 
GSE-7 0.000 0.000 0.000 0.000 ------- ------- 
GSE-8 0.000 0.083 0.000 0.289 -0.63 0.535 
GSE-9 0.200 0.250 0.447 0.452 -0.21 0.838 
GSE-10 0.000 0.083 0.000 0.515 -0.36 0.727 
GSE-Average 0.020 0.075 0.045 0.097 -1.20 0.246 
Smoking Status 
The effect of non-smokers and former smokers were also examined.  There 
were thirteen non-smokers and four former smokers in the survey.  Using a similar 
analysis to that done for age and gender, we find that question SCIMSS-4 was 
statistically different in that former smokers had a larger improvement.  All the 
SCIMSS questions showed larger improvements for former smokers, although 
SCIMSS-4 was the only one which was found to be statistically significant.  
SCIMSS -4 looked at how confident a patient feels that they can keep other 
symptoms or health problems from interfering with things they want to do. For 
patients who were former smokers, following their survivorship follow-up visit, 
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they have increased confidence in managing their other symptoms and health 
problems. The overall SCIMSS average was also determined to be statistically 
significant. This offers insight that patients who are former smokers do report 
higher levels of self-efficacy after their survivorship follow up visits; therefore, 
visits can be amended to highlight this specific subset of head and neck cancer 
patients.  
For the GSE questions, only GSE-2 was found to be statistically significant 
with former smokers having a larger improvement. Question 2 of the GSE survey 
measures how true a patient feels that they can find a way and means to get what 
they want if someone opposes them. Following a survivorship visit, former 
smokers show improved confidence levels; they appear to feel more empowered in 
discussing what they need from someone else. 
Table 7 
 
Self-Efficacy (Smoker) 
  Mean St. Dev. 
t p 
 Questions Non-Smoker 
Former 
Smoker 
Non-
Smoker  
Former 
Smoker 
SCIMSS-1 0.154 0.500 0.376 0.577 -1.53 0.144 
SCIMSS-2 0.154 0.250 0.555 0.500 -0.33 0.744 
SCIMSS-3 -0.308 0.250 0.855 0.500 -1.32 0.207 
SCIMSS-4 -0.077 0.500 0.277 0.577 -3.03 0.008 
SCIMSS-5 -0.077 0.500 0.641 1.000 -1.49 0.155 
SCIMSS-6 -0.077 0.000 0.277 0.000 -0.58 0.568 
SCIMSS-
Average -0.038 0.333 0.227 0.236 -3.05 0.008 
Note. SCIMSS-4 highlighted in bold is statistically significant (p <0.05).  
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Table 8 
 
GSE (Smoker) 
  Mean St. Dev. 
t p 
 Questions 
Non-
Smoker  
Former 
Smoker Non-Smoker  
Former 
Smoker 
GSE-1 0.077 0.000 0.277 0.816 0.33 0.748 
GSE-2 0.077 0.500 0.277 0.577 -2.22 0.041 
GSE-3 0.000 0.000 0.000 0.000 ------- ------- 
GSE-4 0.000 0.000 0.577 0.000 0.00 1.000 
GSE-5 -0.077 0.000 0.277 0.000 -0.58 0.568 
GSE-6 0.077 0.000 0.277 0.000 0.58 0.568 
GSE-7 0.000 0.000 0.000 0.000 ------- ------- 
GSE-8 0.000 0.250 0.000 0.500 -2.10 0.052 
GSE-9 0.308 0.000 0.480 0.000 1.35 0.197 
GSE-10 0.077 0.000 0.494 0.000 0.33 0.748 
GSE-
Average 0.054 0.075 0.088 0.096 -0.44 0.663 
Note. GSE-2 highlighted in bold is statistically significant (p <0.05).  
Ethnicity  
For ethnicity, there were three ethnic groups represented in the sample.  
There were two Asians, thirteen Caucasians, and two Hispanics.  For each 
question, Tables 9 and 10 show the means for the three ethnic groups along with 
the pooled standard deviation.  The statistical test that the three ethnic population 
means are equal is the analysis of variance (ANOVA).  The test statistic is an F.  
The p value is obtained from the F distribution with 2 and 14 degrees of freedom.  
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None of the SCIMSS or GSE questions were statistically significant. Ethnicity was 
not a factor that played a contributing role in affecting the levels of self-efficacy 
following a follow up visit. 
Table 9 
 
SCIMSS (Ethnicity) 
  Mean 
St. Dev. F p 
 Questions Asian  Caucasian Hispanic 
SCIMSS-1 0.000 0.308 0.000 0.445 0.732 0.498 
SCIMSS-2 0.000 0.231 0.000 0.555 0.264 0.771 
SCIMSS-3 0.000 -0.231 0.000 0.858 0.111 0.896 
SCIMSS-4 0.000 0.077 0.000 0.457 0.043 0.958 
SCIMSS-5 0.000 0.077 0.000 0.798 0.014 0.986 
SCIMSS-6 0.000 0.077 0.000 0.257 0.137 0.873 
SCIMSS-Average 0.000 0.064 0.000 0.292 0.074 0.929 
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Table 10 
 
GSE (Ethnicity) 
  Mean 
St. Dev. F p 
 Questions Asian  Caucasian Hispanic 
GSE-1 0.000 0.077 0.000 0.457 0.043 0.958 
GSE-2 0.000 0.231 0.000 0.406 0.494 0.620 
GSE-3 0.000 0.000 0.000 0.000 ------- ------- 
GSE-4 0.000 -0.077 0.500 0.494 0.043 0.956 
GSE-5 0.000 -0.077 0.000 0.257 0.137 0.873 
GSE-6 0.000 0.077 0.000 0.257 0.137 0.873 
GSE-7 0.000 0.000 0.000 0.000 ------- ------- 
GSE-8 0.000 0.308 0.000 0.445 0.137 0.873 
GSE-9 0.000 0.308 0.000 0.445 0.732 0.498 
GSE-10 0.000 -0.077 0.000 0.257 0.137 0.873 
GSE-Average 0.000 0.069 0.050 0.090 0.527 0.601 
This study demonstrates that current survivorship follow- up visits designed 
with a written treatment summary have shown to improve self-efficacy levels 
among head and neck cancer patient survivors. Further analysis looking at the 
effect of several demographics such as age, gender, smoking status and ethnicity, 
showed that patients older than 65 had increased levels of self-efficacy (increased 
confidence in their ability to make decisions and manage their own care) as well as 
those who were former smokers. Ethnicity and gender had no increased self-
efficacy levels following their scheduled survivorship follow up visits.  
It is important to remember that Bandura’s theory of self-efficacy when 
looking at the results of this study. A patient’s self-efficacy level is their 
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willingness and motivations to be able to make the outcomes they want and have 
the confidence to take the actions they need to complete. Previous survivorship 
studies have shown that patients feel more confident that they can make the 
necessary decisions in their own healthcare choices when they receive adequate 
information about their previous treatment and expectations of what is to come in 
the future. This study shows that current survivorship visits at Stanford outpatient 
clinics for the head and neck cancer population do provide the necessary 
information to improve self-efficacy levels.   
Summary 
Seventeen Stanford head and neck cancer patients were given 
questionnaires prior to and after their routine schedule survivorship follow up 
visit.  The survey consisted of two sets of self-evaluation questions.  There were 
six questions in the Self-Efficacy for Managing Chronic Disease (SCIMSS) 
category and ten questions in the General Self-Efficacy (GSE) category.  The 
responses were scored ranging from one to four.   
An analysis was performed on each of the questions to statistically test if 
the population mean scores improved before and after their survivorship transition 
visit with written treatment summary.  The analysis was also performed on the 
averages for the two categories.  Demographics were also tested to see how they 
factored into an effect on the improvement of self-efficacy scores. 
Demographics such as age, gender, ethnicity, and smoking status were also 
looked at to see if these factors had a role in impacting reported self-efficacy 
levels. For demographics, we find that age had a statistically significant effect on 
question GSE-9 with older patients tending to have a greater improvement.  
Gender had no effect on improved scores.  Former smokers had a statistically 
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greater improvement for questions SCIMSS-4 and GSE-2 as well as the average 
SCIMSS score compared to non-smokers. Ethnicity had no effect. 
Questions SCIMSS-1 and GSE-2 were found to have statistically 
significant improvements at the 5% significance level.  The mean average 
improvement for GSE was also determined to be statistically significant. 
Therefore, the hypothesis was proven to be incorrect; current survivorship visits 
have found to be statistically significant in improving self-efficacy of the head and 
neck cancer survivors.  
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CHAPTER 5: CONCLUSION 
The aim of this study was to evaluate how the current survivorship visits at 
Stanford head and neck oncology clinic improve self-efficacy levels of the head 
and neck cancer survivors.  The results of the study support the current non-
standardized survivorship follow up visits to improve self-efficacy levels for the 
head and neck survivor. Healthcare practitioners who completed these 
survivorships follow up visits with written treatment plans and follow up care 
incorporate recommended follow up guidelines for the head and neck cancer 
survivor.  
This study can serve as a pilot study for the Stanford head and neck cancer 
program; it contains a small number of participants. A larger number of 
participants can be recruited when further evaluation of a standardized 
survivorship follow-up visit is conducted. This study was conducted in a short 
duration of time but can be expanded in future studies for repeat measurements on 
levels of self-efficacy. An area of potential study could examine how serial 
survivorship follow ups impact the levels of self-efficacy of head and neck cancer 
survivors. Additional studies can be completed based on this study result to look at 
the levels of self-efficacy change from diagnosis, throughout treatment and 
subsequently after head and neck cancer treatment.   
The results of this study aim to answer the Healthy People 2020 initiative to 
increase the proportion of cancer survivors who are living 5 years or longer after 
diagnosis (U.S. Dept of Health and Human Services [HHS], 2018). The 2005 IOM 
report has made several recommendations in terms of survivorship care; it 
recognized that the quality of care after cancer treatment is lacking and this can 
contribute to a lower number of cancer survivors living more than 5 years after 
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diagnosis. There is a gap in the coordination of care between specialists and 
generalists. This can drastically impact the quality of care and unique needs of 
patient issues after active cancer treatment.  
Mechanisms to ensure increase overall survival and improved quality of life 
for surviving head and neck cancer patients is to empower them with the 
knowledge of their completed treatment plan and provide the expectations of 
follow up care in order to address issues of survivorship. Transition survivorship 
visits should aim to improve self-efficacy levels among head and neck cancer 
survivors. American Cancer Society guidelines and recommendations for follow 
up care can guide the conversations of survivorship issues and facilitate 
communication between cancer specialists and community providers such as the 
primary care physicians. Healthcare professionals and head and neck cancer 
programs need to consider ways to promote higher self-efficacy levels when 
designing their standardized follow up visits.  
Advanced Practice Providers are at the forefront in leading oncology 
survivorship. Advanced nursing healthcare practitioners have a large role in 
improving the multi-disciplinary care of our cancer survivors. Unclear 
expectations of the primary care providers in the long-term management of cancer 
survivors creates a gap in practitioners available to provide this essential patient 
care service. Advanced practice nurses with advanced training in oncology are 
ideal healthcare practitioners who can bridge the gap between the oncology team 
and the primary care team to provide optimal care for cancer survivors. They can 
enhance communication between the various providers, help to implement cancer 
survivorship guidelines, as well as manage acute and chronic post-treatment 
sequelae for the cancer survivor in order to ensure there are higher number of 
cancer survivors at 5-year survival. 
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APPENDIX A: SELF-EFFICACY FOR MANGING CHRONIC 
DISEASE 6-ITEM SCALE  
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APPENDIX B: GENERAL SELF-EFFICACY SCALE 
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